583 results
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... - PPAR gamma agonist ... Amaryl), Glyburide (Diabeta ... AGENTS • GLP-1 agonists ... Hypoglycemics #Diabetes
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... GLP-1 Receptor Agonists ... sarahthelyon #Diabetes
Hyperglycemia - Differential Diagnosis Algorithm
Diabetes Mellitus:
 • Impaired Glucose Tolerance
 • Type I Diabetes
 • Type
Diagnosis Algorithm Diabetes ... Tolerance • Type I Diabetes ... • Type 2 Diabetes ... • Gestational Diabetes ... diuretics • Beta agonists
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... medication in type 2 diabetes ... GLP-1 receptor agonist ... Diabetes Care 2018 ... Diabetes Care 19
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... GLP-1 receptor agonists ... EricsMedicalLectures/featured #diabetes
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
peptide- I receptor agonist ... sulfonylurea; T2D. type 2 diabetes ... type 2 diabetes; ... KDIGO2020 #CKD #Diabetes
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Daily GLP-1 Agonists ... to treat Type 2 Diabetes ... #GLP1 #Agonists ... Pharmacology #Dosing #Diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... GLP-1 receptor agonist ... insulin in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... only) oral GLP1 agonist ... injectable GLP1 agonists ... GLP1 agonists are ... #semaglutide #Diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... GLP1 #Receptor #Agonists ... #Summary #DM2 #diabetes